Cargando…
RET融合基因在非小细胞肺癌诊治中的意义
Lung cancer is the leading cause of cancer-related death worldwide, molecular target therapy has become a hot research direction of non-small cell lung cancer (NSCLC) treatment. RET fusion gene with an identifiable clinical pathological features, is present in some subsets of lung cancer, and its tr...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
中国肺癌杂志编辑部
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6000613/ https://www.ncbi.nlm.nih.gov/pubmed/24229630 http://dx.doi.org/10.3779/j.issn.1009-3419.2013.11.11 |